Stocks and Investing Stocks and Investing
Wed, December 1, 2021
[ 12:00 AM ] - WOPRAI
Ricky Goldwasser Maintained (UNH) at Buy with Increased Target to $526 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Kavin Caliendo Maintained (UNH) at Hold with Increased Target to $452 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
David Macdonald Maintained (UNH) at Strong Buy with Increased Target to $520 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Scott Fidel Maintained (UNH) at Buy with Increased Target to $475 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Manav Gupta Initiated (VTNR) at Buy and Held Target at $13 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Debjit Chattopadhyay Maintained (VRTX) at Strong .. y with Increased Target to $286 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Maintained (VRTX) at Strong Buy with Increased Target to $341 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
David Koning Maintained (V) at Buy and Held Target at $305 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Jim Fontanelli Downgraded (WOLF) to Strong Sell on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Simon Flannery Maintained (CCI) at Buy with Decreased Target to $208 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Ian Gillies Maintained (STN) at Strong Buy and Held Target at $79 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Jason Mollin Initiated (STNE) at Hold and Held Target at $22 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Matthew Bouley Maintained (SWIM) at Buy with Increased Target to $30 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Edward White Maintained (TGTX) at Strong Buy with Decreased Target to $75 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Maintained (TGTX) at Strong Sell with Decreased Target to $13 on, Dec 1st, 2021
[ 12:00 AM ] - WOPRAI
Joshua Schimmer Maintained (TGTX) at Buy with Decreased Target to $36 on, Dec 1st, 2021
Tue, November 30, 2021
[ 12:00 AM ] - WOPRAI
Joshua Spector Upgraded (TROX) to Strong Buy and Increased Target to $32 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Maintained (SYNA) at Buy with Increased Target to $310 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
David George Maintained (TFC) at Hold and Held Target at $57 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Jason Kupferberg Upgraded (SQ) to Hold and Increased Target to $221 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Ronald Epstein Initiated (SPIR) at Hold and Held Target at $40 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Sidney Ho Initiated (SMRT) at Strong Buy and Held Target at $16 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Michael Perito Initiated (SOFI) at Hold and Held Target at $21 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
John Staszak Downgraded (CENTA) to Hold on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
John Staszak Downgraded (CENT) to Hold on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Daniel Ives Initiated (CCSI) at Buy and Held Target at $75 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
James Thalacker Initiated (WEC) at Hold on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
David George Maintained (WFC) at Buy and Held Target at $50 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Jason Fairclough Maintained (VALE) at Hold with Decreased Target to $17 on, Nov 30th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $200 on, Nov 30th, 2021

Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $200 on, Nov 30th, 2021


Published on 2024-10-27 18:49:10 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Increased Target from $135 to $200 on, Nov 30th, 2021.

Patrick has made no other calls on VIR in the last 4 months.



There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $37 on, Monday, October 25th, 2021
  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021


This is the rating of the analyst that currently disagrees with Patrick

  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021
Contributing Sources